Comparison of gastrointestinal pH in dogs and humans: implications on the use of the beagle dog as a model for oral absorption in humans.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of Pharmacy and Science

• Publication date

  1986-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/JPS.2600750313PMID 3701609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiotelemetric determination of gastrointestinal pH in four healthy beagles.

  1985cited by this paper
• Radiotelemetric method for evaluating enteric coatings in vivo.

  1984cited by this paper
• Physicochemical model for dose-dependent drug absorption.

  1984cited by this paper
• Animal models for oral drug delivery in man : in situ and in vivo approaches

  1983cited by this paper
• High-performance liquid chromatographic determination of aspirin and its metabolites in plasma and urine.

  1983cited by this paper
• Intestinal absorption of amino acid derivatives: importance of the free alpha-amino group.

  1982cited by this paper
• Gastric pH changes associated with duodenal motility in fasted dogs.

  1981cited by this paper
• Improving intestinal absorption of water-insoluble compounds: a membrane metabolism strategy.

  1980cited by this paper
• A convective mass transfer model for determining intestinal wall permeabilities: laminar flow in a circular tube.

  1980cited by this paper
• Influence of exocrine pancreatic insufficiency on the intraluminal pH of the proximal small intestine

  1979cited by this paper
• Apparent dose-dependent absorption of chlorothiazide in dogs

  1979cited by this paper
• Shift of pH-absorption curves

  1977cited by this paper
• Pharmacokinetics of the anticonvulsant drug clonazepam evaluated from single oral and intravenous doses and by repeated oral administration

  1975cited by this paper
• Pharmacokinetic profiles of clonazepam in dog and humans and of flunitrazepam in dog.

  1974cited by this paper
• Absorption kinetics of aspirin in man following oral administration of an aqueous solution.

  1972cited by this paper
• Effect of secretin on fasting and postprandial pH of the duodenal bulb in dogs.

  1970cited by this paper
• pH of the duodenum of patients with and without duodenal ulcers measured with a radiotelemetering capsule.

  1969cited by this paper
• Influence of the route of administration on the area under the plasma concentration-time curve.

  1969cited by this paper
• Applied Regression Analysis.

  1967cited by this paper
• Effect of duodenal alkalinization of gastric motility.

  1966cited by this paper
• THE REACTION OF THE CONTENT OF THE GASTRO-INTESTINAL TRACT

  1930cited by this paper

• Highly Pathogenic Avian Influenza (HPAI) H5N1 in Raw Pet Foods and Milk: A Growing Threat to both Companion Animals and Human Health, and Potential Raw Pet Food Industry Liability.

  2025cites this paper
• Fasting improves oral bioavailability of mitragynine in healthy female Beagles.

  2025cites this paper
• A Bottom-up Approach for Mutant and Wild Type Collies Using Physiologically Based Pharmacokinetic (PBPK) Modeling: A Case Study Using Loperamide

  2025cites this paper
• Cannabidiol lymphatic transport after oral administration assessed using a novel thoracic lymph duct cannulated conscious pig model

  2025cites this paper
• Investigating the effect of permeation enhancers on oral absorption of a BCS IV compound, ombitasvir, utilizing animal models.

  2025cites this paper
• Transformative Paths: Preclinical Drug Formulation and Delivery Approaches in Development.

  2025cites this paper
• State-of-the-Art and Future Perspectives in Ingestible Remotely Controlled Smart Capsules for Drug Delivery: A GENEGUT Review.

  2024cites this paper
• Effect of particle size on gastric emptying of enteric-coated granules in fasted beagle dogs: Relationship with interdigestive migrating motor complex.

  2024cites this paper
• Assessing and mitigating pH-mediated DDI risks in drug development – formulation approaches and clinical considerations

  2024cites this paper
• 3D Printed pH-responsive Colonic Capsules for the Delivery of Live Aqueous Bacterial Suspensions

  2024cites this paper
• Soft autonomous ingestible device for sampling the small-intestinal microbiome

  2024cites this paper
• Characterizing interspecies differences in gastric fluid properties to improve understanding of in vivo oral drug formulation performance.

  2023cites this paper
• HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

  2023cites this paper
• From Chihuahua to Saint-Bernard: how did digestion and microbiota evolve with dog sizes

  2022cites this paper
• In vitro models of the canine digestive tract as an alternative to in vivo assays: Advances and current challenges.

  2022influential citation
• Preclinical and Clinical Pharmacokinetics and Bioavailability in Healthy Volunteers of a Novel Formulation of the Selective P2X3 Receptor Antagonist Eliapixant

  2022cites this paper
• Animal Models in Toxicologic Research: Dog

  2022cites this paper
• Establishment of Level a In Vitro–In Vivo Correlation (IVIVC) via Extended DoE-IVIVC Model: A Donepezil Case Study

  2022cites this paper
• Novel extended IVIVC combined with DoE to predict pharmacokinetics from formulation compositions.

  2022cites this paper
• Absorption, Distribution, Metabolism, and Excretion of [14C]-Sotorasib in Rats and Dogs: Interspecies Differences in Absorption, Protein Conjugation and Metabolism

  2022cites this paper
• Gastrointestinal transit time is faster in Beagle dogs compared to cats.

  2022cites this paper
• Dietary protein sources and their effects on faecal odour and the composition of volatile organic compounds in faeces of French Bulldogs.

  2021cites this paper
• Exploitation of nanocrystal suspension as an effective oral formulation for oxfendazole

  2021cites this paper
• Effect of gastric residence time on the oral absorption of rebamipide sustained-release tablets in beagle dogs

  2021cites this paper
• Lost in modelling and simulation?

  2021cites this paper
• Formulation strategies to improve the efficacy of intestinal permeation enhancers.

  2021cites this paper
• Crosstalk of physiological pH and chemical pKa under the umbrella of physiologically based pharmacokinetic modeling of drug absorption, distribution, metabolism, excretion, and toxicity

  2021cites this paper
• Considerations for application of biopharmaceutics classification system in chicken: Exemplified by seven drugs classification.

  2020cites this paper
• Discovery of T-1101 tosylate as a first-in-class clinical candidate for Hec1/Nek2 inhibition in cancer therapy.

  2020cites this paper
• Effect of Zinc Source and Exogenous Enzymes Supplementation on Zinc Status in Dogs Fed High Phytate Diets

  2020cites this paper
• In vivo screening of oral formulations using rats: Effects of ingested water volume on oral absorption of BCS class I and III drugs from immediate-release formulations

  2020cites this paper
• pH-dependent ileocolonic drug delivery, part I: in vitro and clinical evaluation of novel systems.

  2020cites this paper
• The past, present and future of intestinal in vitro cell systems for drug absorption studies.

  2020cites this paper
• Development of a Population Pharmacokinetics-Based in vitro-in vivo Correlation Model for Drugs with Site-Dependent Absorption: the Acyclovir Case Study

  2020cites this paper
• Extent and rate of oral drug absorption in minipigs: Comparison with mice, rats and humans

  2020cites this paper
• In vitro and in vivo behavior of KinetiSol® and spray dried amorphous solid dispersions of a weakly basic drug and ionic polymer.

  2020cites this paper
• New Preclinical Development of a c-Met Inhibitor and Its Combined Anti-Tumor Effect in c-Met-Amplified NSCLC

  2020cites this paper
• pH-dependent ileocolonic drug delivery, part II: preclinical evaluation of novel drugs and novel excipients.

  2020cites this paper
• Prediction Accuracy of Mechanism-Based Oral Absorption Model for Dogs.

  2019cites this paper
• Development of Gabapentin Expandable Gastroretentive Controlled Drug Delivery System

  2019cites this paper
• Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface.

  2019cites this paper
• Double controlled release of highly insoluble cilostazol using surfactant‐driven pH dependent and pH‐independent polymeric blends and in vivo bioavailability in beagle dogs

  2019cites this paper
• Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study

  2019cites this paper
• Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update

  2019cites this paper
• Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule

  2019cites this paper
• Mechanistic understanding of bioenabling formulation approaches to improve oral bioavailability using porcine in vivo and in silico models

  2018cites this paper
• Preclinical pharmacokinetics of benznidazole‐loaded interpolyelectrolyte complex‐based delivery systems

  2018cites this paper
• Evaluation of Using Dogs to Predict Fraction of Oral Dose Absorbed in Humans for Poorly Water-Soluble Drugs.

  2018cites this paper
• Toxicokinetics and Drug Disposition

  2018cites this paper
• Using pH Gradient Dissolution with In-Situ Flux Measurement to Evaluate Bioavailability and DDI for Formulated Poorly Soluble Drug Products

  2018cites this paper
• Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.

  2017cites this paper
• Bioavailability of Oral Colon-Specific Ketoprofen Microcapsules

  2017cites this paper
• Solubility Criteria for Veterinary Drugs

  2017cites this paper
• ZY15557, a novel, long acting inhibitor of dipeptidyl peptidase‐4, for the treatment of Type 2 diabetes mellitus

  2017cites this paper
• Exploring Canine-Human Differences in Product Performance. Part II: Use of Modeling and Simulation to Explore the Impact of Formulation on Ciprofloxacin In Vivo Absorption and Dissolution in Dogs

  2017cites this paper
• Considerations for the development of in vitro dissolution tests to reduce or replace preclinical oral absorption studies

  2017cites this paper
• Drug Classification and Drug Disposition Prediction

  2017cites this paper
• Minimally invasive wireless motility capsule to study canine gastrointestinal motility and pH.

  2017cites this paper
• Food Effect on Oral Bioavailability: Old and New Questions

  2017cites this paper
• Effect of hospitalization on gastrointestinal motility and pH in dogs.

  2017cites this paper
• Discovery of the Irreversible Covalent FGFR Inhibitor 8-(3-(4-Acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (PRN1371) for the Treatment of Solid Tumors.

  2017cites this paper
• GIT Anatomy and Physiology and Drug Oral Bioavailability: Impact of Species Differences

  2017cites this paper
• Predicting Drug Disposition by Integrating In Vitro and In Silico Methodology

  2016cites this paper
• Key Considerations in Designing Oral Drug Delivery Systems for Dogs.

  2016cites this paper
• Prediction of positive food effect: Bioavailability enhancement of BCS class II drugs.

  2016cites this paper
• Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives.

  2016cites this paper
• Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam

  2016influential citation
• The Guinea Pig

  2016cites this paper
• Diagnosing Biopharmaceutical Limitations

  2015cites this paper
• Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization.

  2015cites this paper
• Evaluation of the use of Göttingen minipigs to predict food effects on the oral absorption of drugs in humans.

  2015cites this paper
• Discovery Formulations: Approaches and Practices in Early Preclinical Development

  2015cites this paper
• Oral Delivery of Therapeutic Proteins and Peptides: An Overview of Current Technologies and Recommendations for Bridging from Approved Intravenous or Subcutaneous Administration to Novel Oral Regimens

  2015cites this paper
• spray‐dried in a Büchi mini spray‐dryer (Model B295, Büchi, Flawil, Switzerland) using a two‐fluid 6

  2015cites this paper
• Evaluation of Acid Tolerance of Drugs Using Rats and Dogs Controlled for Gastric Acid Secretion.

  2015cites this paper
• pH-Dependent Liquid-Liquid Phase Separation of Highly Supersaturated Solutions of Weakly Basic Drugs.

  2015cites this paper
• Evidence for Human Norovirus Infection of Dogs in the United Kingdom

  2015cites this paper
• Enantioselective Pharmacokinetics of α-Lipoic Acid in Rats

  2015cites this paper
• Food Effect in Humans: Predicting the Risk Through In Vitro Dissolution and In Vivo Pharmacokinetic Models

  2015cites this paper
• Animal Farm: Considerations in Animal Gastrointestinal Physiology and Relevance to Drug Delivery in Humans.

  2015cites this paper
• Evolving Biopharmaceutics Perspectives for Hydrophilic Matrix Tablets: Dosage Form–Food Interactions and Dosage Form Gastrointestinal Tract Interactions

  2014cites this paper
• Physiologically Based Pharmacokinetic Modeling in the Development and Evaluation of Hydrophilic Matrix Tablets

  2014cites this paper
• Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS).

  2014cites this paper
• Hydrophilic Matrix Tablets for Oral Controlled Release

  2014cites this paper
• In vivo methods for drug absorption - comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects.

  2014cites this paper
• Composition and physicochemical properties of fasted-state human duodenal and jejunal fluid: a critical evaluation of the available data.

  2014cites this paper
• The biopharmaceutics risk assessment roadmap for optimizing clinical drug product performance.

  2014cites this paper
• Microenvironmental pH-modification to improve dissolution behavior and oral absorption for drugs with pH-dependent solubility

  2014cites this paper
• Formulation of itraconazole nanococrystals and evaluation of their bioavailability in dogs.

  2014cites this paper
• Quantitative ADME Proteomics – CYP and UGT Enzymes in the Beagle Dog Liver and Intestine

  2014cites this paper
• 1 PHYSIOLOGICAL BARRIERS IN ADVANCED DRUG DELIVERY : GASTROINTESTINAL BARRIER

  2013cites this paper
• ASIAN FOOD (CARBOHYDRATE, PROTEIN, FAT) INCREASE SIMVASTATIN BIOAVAILABILITY ESPECIALLY IN MALAYSIAN SUBJECTS

  2013cites this paper
• Oral Anatomy and Physiology in the Companion Animal

  2013cites this paper
• Pharmacokinetics and absorption of the anticancer agents dasatinib and GDC-0941 under various gastric conditions in dogs--reversing the effect of elevated gastric pH with betaine HCl.

  2013cites this paper
• Dissolution media simulating the proximal canine gastrointestinal tract in the fasted state.

  2013cites this paper
• Investigation of the rat model for preclinical evaluation of pH-dependent oral absorption in humans.

  2013cites this paper
• In Vitro Investigations into the Roles of Drug Transporters and Metabolizing Enzymes in the Disposition and Drug Interactions of Dolutegravir, a HIV Integrase Inhibitor

  2013influential citation
• A Physiologically Based Pharmacokinetic Model of the Minipig: Data Compilation and Model Implementation

  2012cites this paper
• Oral enzyme therapy for celiac sprue.

  2012influential citation
• Mucoadhesive tablets for controlled release of acyclovir.

  2012cites this paper